Bryan, Garnier & Co strengthens its Healthcare team with the hiring of Jean-Jacques Le Fur as Senior Financial Analyst
PARIS, August 28th, 2018 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is delighted to welcome Jean-Jacques Le Fur to its European Healthcare team.
With over 20 years of experience as a sell side analyst in European pharmaceuticals, Jean-Jacques will join the Healthcare team as an analyst and will help Bryan, Garnier & Co to leverage its footprint within the Healthcare sector.
Before joining Bryan, Garnier & Co, Jean-Jacques was a senior Pharmaceutical analyst at Oddo-BHF and Natixis. Before life as an analyst, he held various positions in R&D and Finance at Hoechst-Marion-Roussel and Ipsen.
Eric Le Berrigaud, Managing Partner in Paris comments: “I have known Jean-Jacques for many years and I am delighted to have him join us to take our already very successful healthcare practice to the next level. The new team will have the objective of covering more companies across all segments, increasing the number of client events as well actively being involved in more transactions.”
Jean-Jacques Le Fur adds: “Bryan Garnier & Co is a leader in the Healthcare sector combining stock market and banking services with an entrepreneurial culture. I look forward to contributing to the continued development of the Healthcare team and transforming ideas into opportunities for our clients.”
Jean-Jacques holds a degree in Pharmacy (PharmD) from Paris University as well as an MBA, from IAE, Paris.
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European, full-service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Stockholm, Oslo and Reykjavik as well as New York and Palo Alto. The firm is a member of the London Stock Exchange.